april pharmacy limited
april pharmacy limited Company Information
Company Number
06797687
Next Accounts
Feb 2025
Industry
Activities of head offices
Shareholders
archibald reginald unger
monika joanna syska-unger
Group Structure
View All
Contact
Registered Address
fifth floor watson house, 54-60 baker street, london, W1U 7BU
Website
-april pharmacy limited Estimated Valuation
Pomanda estimates the enterprise value of APRIL PHARMACY LIMITED at £452.7k based on a Turnover of £888.7k and 0.51x industry multiple (adjusted for size and gross margin).
april pharmacy limited Estimated Valuation
Pomanda estimates the enterprise value of APRIL PHARMACY LIMITED at £0 based on an EBITDA of £0 and a 3.78x industry multiple (adjusted for size and gross margin).
april pharmacy limited Estimated Valuation
Pomanda estimates the enterprise value of APRIL PHARMACY LIMITED at £533.2k based on Net Assets of £250k and 2.13x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
April Pharmacy Limited Overview
April Pharmacy Limited is a live company located in london, W1U 7BU with a Companies House number of 06797687. It operates in the activities of head offices sector, SIC Code 70100. Founded in January 2009, it's largest shareholder is archibald reginald unger with a 52% stake. April Pharmacy Limited is a established, small sized company, Pomanda has estimated its turnover at £888.7k with rapid growth in recent years.
Upgrade for unlimited company reports & a free credit check
April Pharmacy Limited Health Check
Pomanda's financial health check has awarded April Pharmacy Limited a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 2 areas for improvement. Company Health Check FAQs
3 Strong
3 Regular
2 Weak
Size
annual sales of £888.7k, make it smaller than the average company (£19.5m)
- April Pharmacy Limited
£19.5m - Industry AVG
Growth
3 year (CAGR) sales growth of 38%, show it is growing at a faster rate (5.1%)
- April Pharmacy Limited
5.1% - Industry AVG
Production
with a gross margin of 33.3%, this company has a comparable cost of product (33.3%)
- April Pharmacy Limited
33.3% - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- April Pharmacy Limited
- - Industry AVG
Employees
with 2 employees, this is below the industry average (109)
2 - April Pharmacy Limited
109 - Industry AVG
Pay Structure
on an average salary of £47.4k, the company has an equivalent pay structure (£47.4k)
- April Pharmacy Limited
£47.4k - Industry AVG
Efficiency
resulting in sales per employee of £444.3k, this is more efficient (£196k)
- April Pharmacy Limited
£196k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- April Pharmacy Limited
- - Industry AVG
Creditor Days
its suppliers are paid after 171 days, this is slower than average (44 days)
- April Pharmacy Limited
44 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- April Pharmacy Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - April Pharmacy Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 52.7%, this is a similar level of debt than the average (56.3%)
52.7% - April Pharmacy Limited
56.3% - Industry AVG
APRIL PHARMACY LIMITED financials
April Pharmacy Limited's latest turnover from May 2023 is estimated at £888.7 thousand and the company has net assets of £250 thousand. According to their latest financial statements, April Pharmacy Limited has 2 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| May 2023 | May 2022 | May 2021 | May 2020 | May 2019 | May 2018 | May 2017 | May 2016 | May 2015 | May 2014 | May 2013 | May 2012 | May 2011 | Jan 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | ||||||||||||||
| Other Income Or Grants | ||||||||||||||
| Cost Of Sales | ||||||||||||||
| Gross Profit | ||||||||||||||
| Admin Expenses | ||||||||||||||
| Operating Profit | ||||||||||||||
| Interest Payable | ||||||||||||||
| Interest Receivable | ||||||||||||||
| Pre-Tax Profit | ||||||||||||||
| Tax | ||||||||||||||
| Profit After Tax | ||||||||||||||
| Dividends Paid | ||||||||||||||
| Retained Profit | ||||||||||||||
| Employee Costs | ||||||||||||||
| Number Of Employees | 2 | 2 | 2 | 2 | 2 | |||||||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| May 2023 | May 2022 | May 2021 | May 2020 | May 2019 | May 2018 | May 2017 | May 2016 | May 2015 | May 2014 | May 2013 | May 2012 | May 2011 | Jan 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 527,982 | 527,982 | 807,982 | 807,982 | 807,984 | 807,983 | 807,983 | 807,983 | 807,983 | 807,983 | 807,983 | 807,983 | 807,983 | 807,983 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 527,982 | 527,982 | 807,982 | 807,982 | 807,984 | 807,983 | 807,983 | 807,983 | 807,983 | 807,983 | 807,983 | 807,983 | 807,983 | 807,983 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 916,009 | 0 | 0 | 0 | 0 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2,261 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 916,009 | 0 | 0 | 0 | 2,261 |
| total assets | 527,982 | 527,982 | 807,982 | 807,982 | 807,984 | 807,983 | 807,983 | 807,983 | 807,983 | 1,723,992 | 807,983 | 807,983 | 807,983 | 810,244 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 278,011 | 278,011 | 0 | 0 | 0 | 0 | 0 | 0 | 800,760 | 703,890 | 208,712 | 82,270 | 308,119 | 322,739 |
| Group/Directors Accounts | 0 | 0 | 558,010 | 558,010 | 408,501 | 448,501 | 448,501 | 409,552 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 0 | 0 | 1 | 22,751 | 172,260 | 352,260 | 252,260 | 391,208 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current liabilities | 278,011 | 278,011 | 558,011 | 580,761 | 580,761 | 800,761 | 700,761 | 800,760 | 800,760 | 703,890 | 208,712 | 82,270 | 308,119 | 322,739 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1,012,880 | 592,048 | 720,481 | 510,632 | 497,158 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1,012,880 | 592,048 | 720,481 | 510,632 | 497,158 |
| total liabilities | 278,011 | 278,011 | 558,011 | 580,761 | 580,761 | 800,761 | 700,761 | 800,760 | 800,760 | 1,716,770 | 800,760 | 802,751 | 818,751 | 819,897 |
| net assets | 249,971 | 249,971 | 249,971 | 227,221 | 227,223 | 7,222 | 107,222 | 7,223 | 7,223 | 7,222 | 7,223 | 5,232 | -10,768 | -9,653 |
| total shareholders funds | 249,971 | 249,971 | 249,971 | 227,221 | 227,223 | 7,222 | 107,222 | 7,223 | 7,223 | 7,222 | 7,223 | 5,232 | -10,768 | -9,653 |
| May 2023 | May 2022 | May 2021 | May 2020 | May 2019 | May 2018 | May 2017 | May 2016 | May 2015 | May 2014 | May 2013 | May 2012 | May 2011 | Jan 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||
| Operating Profit | ||||||||||||||
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | ||||||||||||||
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -916,009 | 916,009 | 0 | 0 | 0 | 0 |
| Creditors | 0 | 278,011 | 0 | 0 | 0 | 0 | 0 | -800,760 | 96,870 | 495,178 | 126,442 | -225,849 | -14,620 | 322,739 |
| Accruals and Deferred Income | 0 | -1 | -22,750 | -149,509 | -180,000 | 100,000 | -138,948 | 391,208 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | ||||||||||||||
| Investing Activities | ||||||||||||||
| capital expenditure | ||||||||||||||
| Change in Investments | 0 | -280,000 | 0 | -2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 807,983 |
| cash flow from investments | ||||||||||||||
| Financing Activities | ||||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | -558,010 | 0 | 149,509 | -40,000 | 0 | 38,949 | 409,552 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1,012,880 | 420,832 | -128,433 | 209,849 | 13,474 | 497,158 |
| share issue | ||||||||||||||
| interest | ||||||||||||||
| cash flow from financing | ||||||||||||||
| cash and cash equivalents | ||||||||||||||
| cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2,261 | 2,261 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2,261 | 2,261 |
april pharmacy limited Credit Report and Business Information
April Pharmacy Limited Competitor Analysis
Perform a competitor analysis for april pharmacy limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other small companies, companies in W1U area or any other competitors across 12 key performance metrics.
april pharmacy limited Ownership
APRIL PHARMACY LIMITED group structure
April Pharmacy Limited has 2 subsidiary companies.
Ultimate parent company
APRIL PHARMACY LIMITED
06797687
2 subsidiaries
april pharmacy limited directors
April Pharmacy Limited currently has 2 directors. The longest serving directors include Mr Archibald Unger (Jan 2009) and Mrs Monika Syska-Unger (Feb 2009).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Archibald Unger | United Kingdom | 56 years | Jan 2009 | - | Director |
| Mrs Monika Syska-Unger | United Kingdom | 51 years | Feb 2009 | - | Director |
P&L
May 2023turnover
888.7k
+7%
operating profit
0
0%
gross margin
33.4%
+1.7%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
May 2023net assets
250k
0%
total assets
528k
0%
cash
0
0%
net assets
Total assets minus all liabilities
april pharmacy limited company details
company number
06797687
Type
Private limited with Share Capital
industry
70100 - Activities of head offices
incorporation date
January 2009
age
16
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
May 2023
previous names
N/A
accountant
-
auditor
-
address
fifth floor watson house, 54-60 baker street, london, W1U 7BU
Bank
-
Legal Advisor
-
april pharmacy limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 4 charges/mortgages relating to april pharmacy limited. Currently there are 3 open charges and 1 have been satisfied in the past.
april pharmacy limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for APRIL PHARMACY LIMITED. This can take several minutes, an email will notify you when this has completed.
april pharmacy limited Companies House Filings - See Documents
| date | description | view/download |
|---|
